Edward J Calabrese
Principles of Animal Extrapolation (1991)
Edward J Calabrese
Principles of Animal Extrapolation (1991)
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Principles of Animal Extrapolation addresses the conceptual basis for animal extrapolation and provides an abundance of documentation that illustrates how these principles may be applied in the selection of the more appropriate models and in the interpretation of toxicological studies.
Andere Kunden interessierten sich auch für
- Mark Edward ByrnesField Sampling Methods for Remedial Investigations160,99 €
- Frank L CrossSizing and Selecting Air Pollution Control Systems201,99 €
- Michael CurleyEnvironmental Finance for the Developing World156,99 €
- Tropospheric Aerosol-Formation, Transformation, Fate and Impacts252,99 €
- Biomarkers and Human Biomonitoring, Volume 2186,99 €
- Environmental Cardiology184,99 €
- Biomarkers and Human Biomonitoring, Volume 1188,99 €
-
-
-
Principles of Animal Extrapolation addresses the conceptual basis for animal extrapolation and provides an abundance of documentation that illustrates how these principles may be applied in the selection of the more appropriate models and in the interpretation of toxicological studies.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis Ltd (Sales)
- Seitenzahl: 616
- Erscheinungstermin: 20. September 2017
- Englisch
- Abmessung: 234mm x 156mm x 33mm
- Gewicht: 1034g
- ISBN-13: 9781138505872
- ISBN-10: 1138505870
- Artikelnr.: 50495454
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
- Verlag: Taylor & Francis Ltd (Sales)
- Seitenzahl: 616
- Erscheinungstermin: 20. September 2017
- Englisch
- Abmessung: 234mm x 156mm x 33mm
- Gewicht: 1034g
- ISBN-13: 9781138505872
- ISBN-10: 1138505870
- Artikelnr.: 50495454
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
Edward J. Calabrese is a board certified toxicologist who is Professor of Toxicology at the University of Massachusetts School of Pubic Health, Amherst. Dr. Calabrese has researched extensively in the area of host factors affecting susceptibility to pollutants and is the author off more than 300 papers in scholarly journals, as well as 12 books.
1. ANIMAL EXTRAPOLATION: AN INTRODUCTION. Federal Legislation and
Predictive Toxicology. The Early Use of Animal Models. How Much Testing Is
Needed? Are Perfect Testing Schemes Possible? Inadequacies of Present
Predictive Schemes. Animal Rights, Humane Considerations, and Human Needs.
Educating the Public: Perception Versus Reality. Regulatory Needs.
2. ABSORPTION: INTERSPECIES DIFFERENCES. The Gastrointestinal Tract. Dermal
Absorption. Respiratory Tract Absorption.
3. INTESTINAL MICROFLORA. Introduction. Interspecies Differences. Summary.
4. TISSUE DISTRIBUTION: INTERSPECIES DIFFERENCES. Protein Binding. Biliary
Excretion. The Blood-Brain Barrier: The Toxicological Implications of
Interspecies Differences in Maturation. Interspecies Differences in the
Tissue Distribution of Mercury.
5. COMPARATIVE METABOLISM: THE PRINCIPAL CAUSE OF DIFFERENTIAL
SUSCEPTIBILITY TO TOXIC AND CARCINOGENIC AGENTS. General Principles.
Organophosphate Insecticides: A Specific Application. Other Examples.
6. A REEVALUATION OF THE RAT AS A LABORATORY ANIMAL.
7. ANIMAL MODELS FOR SELECTED HIGH-RISK GROUPS. Introduction. Hereditary
Blood Disorders. White Blood Cells: Interspecies Differences in the
Detoxification of Hydrogen Peroxide by Polymorphonuclear Leukocytes.
Cardiovascular Disease Models. Sulfite Oxidase Deficiency in the Hepatic
Disease Model: A High-Risk Factor in Sulfur Dioxide, Sulfite, and Bisulfite
Toxicity, and Possible Animal Models. Respiratory Disorders.
8. DERMATOXICITY: PREDICTIVE MODELS. Ocular Toxicity. Contact Dermatitis.
Allergic Hypersensitivity. Phototoxicity.
9. GENOTOXICITY: PREDICTIVE MODELS. The Relationship of Mutagenicity to
Carcinogenicity. Quantitative Interspecies Comparisons of Genetic Damage.
An Attempt to Establish the Biological Basis of Interspecies Predictions of
Mutation Rates.
10. DNA REPAIR: INTERSPECIES DIFFERENCES. Introduction. DNA Repair and
Carcinogenesis. Interspecies Comparisons of DNA Repair Processes. Summary.
11. TERATOGENICITY: PREDICTIVE MODELS. The Use of Predictive Animal Models
in Teratogenicity Testing Before the Thalidomide Tragedy. The Predictive
Potential of Animal Models. New Approaches. Interspecies Differences in
Metabolism. Comparative Placental Morphology and Function in Animal Models.
Discussion and Conclusions.
12 SCALING: AN ATTEMPT TO FIND A COMMON DENOMINATOR. Introduction. The
Scaling Concept. Pharmacokinetics: Dependence on Body Weight. The Use of
Scaling in Carcinogen Evaluation. The use of Allometry in Extrapolation: A
Summary. Lifespan, a Common Denominator for Interspecies Comparisons in
Carcinogenicity Studies: Another Example of Scaling Effects.
13 DOWNWARD EXTRAPOLATION. Establishing Dose-Response Relationships. Safety
Factors. Attempts to Determine Safe Doses for Carcinogens. Latency as a
Function of Dose in Cancer Development. Quantitative Approaches to Downward
Extrapolation. The Biological Plausibility of the Models. Attempts to
Validate Downward Extrapolation Models. The Use of Quantitative Risk
Evaluation by U.S. Regulatory Agencies.
14 ANIMAL EXTRAPOLATION: A SUMMARY. INDEX.
Predictive Toxicology. The Early Use of Animal Models. How Much Testing Is
Needed? Are Perfect Testing Schemes Possible? Inadequacies of Present
Predictive Schemes. Animal Rights, Humane Considerations, and Human Needs.
Educating the Public: Perception Versus Reality. Regulatory Needs.
2. ABSORPTION: INTERSPECIES DIFFERENCES. The Gastrointestinal Tract. Dermal
Absorption. Respiratory Tract Absorption.
3. INTESTINAL MICROFLORA. Introduction. Interspecies Differences. Summary.
4. TISSUE DISTRIBUTION: INTERSPECIES DIFFERENCES. Protein Binding. Biliary
Excretion. The Blood-Brain Barrier: The Toxicological Implications of
Interspecies Differences in Maturation. Interspecies Differences in the
Tissue Distribution of Mercury.
5. COMPARATIVE METABOLISM: THE PRINCIPAL CAUSE OF DIFFERENTIAL
SUSCEPTIBILITY TO TOXIC AND CARCINOGENIC AGENTS. General Principles.
Organophosphate Insecticides: A Specific Application. Other Examples.
6. A REEVALUATION OF THE RAT AS A LABORATORY ANIMAL.
7. ANIMAL MODELS FOR SELECTED HIGH-RISK GROUPS. Introduction. Hereditary
Blood Disorders. White Blood Cells: Interspecies Differences in the
Detoxification of Hydrogen Peroxide by Polymorphonuclear Leukocytes.
Cardiovascular Disease Models. Sulfite Oxidase Deficiency in the Hepatic
Disease Model: A High-Risk Factor in Sulfur Dioxide, Sulfite, and Bisulfite
Toxicity, and Possible Animal Models. Respiratory Disorders.
8. DERMATOXICITY: PREDICTIVE MODELS. Ocular Toxicity. Contact Dermatitis.
Allergic Hypersensitivity. Phototoxicity.
9. GENOTOXICITY: PREDICTIVE MODELS. The Relationship of Mutagenicity to
Carcinogenicity. Quantitative Interspecies Comparisons of Genetic Damage.
An Attempt to Establish the Biological Basis of Interspecies Predictions of
Mutation Rates.
10. DNA REPAIR: INTERSPECIES DIFFERENCES. Introduction. DNA Repair and
Carcinogenesis. Interspecies Comparisons of DNA Repair Processes. Summary.
11. TERATOGENICITY: PREDICTIVE MODELS. The Use of Predictive Animal Models
in Teratogenicity Testing Before the Thalidomide Tragedy. The Predictive
Potential of Animal Models. New Approaches. Interspecies Differences in
Metabolism. Comparative Placental Morphology and Function in Animal Models.
Discussion and Conclusions.
12 SCALING: AN ATTEMPT TO FIND A COMMON DENOMINATOR. Introduction. The
Scaling Concept. Pharmacokinetics: Dependence on Body Weight. The Use of
Scaling in Carcinogen Evaluation. The use of Allometry in Extrapolation: A
Summary. Lifespan, a Common Denominator for Interspecies Comparisons in
Carcinogenicity Studies: Another Example of Scaling Effects.
13 DOWNWARD EXTRAPOLATION. Establishing Dose-Response Relationships. Safety
Factors. Attempts to Determine Safe Doses for Carcinogens. Latency as a
Function of Dose in Cancer Development. Quantitative Approaches to Downward
Extrapolation. The Biological Plausibility of the Models. Attempts to
Validate Downward Extrapolation Models. The Use of Quantitative Risk
Evaluation by U.S. Regulatory Agencies.
14 ANIMAL EXTRAPOLATION: A SUMMARY. INDEX.
1. ANIMAL EXTRAPOLATION: AN INTRODUCTION. Federal Legislation and
Predictive Toxicology. The Early Use of Animal Models. How Much Testing Is
Needed? Are Perfect Testing Schemes Possible? Inadequacies of Present
Predictive Schemes. Animal Rights, Humane Considerations, and Human Needs.
Educating the Public: Perception Versus Reality. Regulatory Needs.
2. ABSORPTION: INTERSPECIES DIFFERENCES. The Gastrointestinal Tract. Dermal
Absorption. Respiratory Tract Absorption.
3. INTESTINAL MICROFLORA. Introduction. Interspecies Differences. Summary.
4. TISSUE DISTRIBUTION: INTERSPECIES DIFFERENCES. Protein Binding. Biliary
Excretion. The Blood-Brain Barrier: The Toxicological Implications of
Interspecies Differences in Maturation. Interspecies Differences in the
Tissue Distribution of Mercury.
5. COMPARATIVE METABOLISM: THE PRINCIPAL CAUSE OF DIFFERENTIAL
SUSCEPTIBILITY TO TOXIC AND CARCINOGENIC AGENTS. General Principles.
Organophosphate Insecticides: A Specific Application. Other Examples.
6. A REEVALUATION OF THE RAT AS A LABORATORY ANIMAL.
7. ANIMAL MODELS FOR SELECTED HIGH-RISK GROUPS. Introduction. Hereditary
Blood Disorders. White Blood Cells: Interspecies Differences in the
Detoxification of Hydrogen Peroxide by Polymorphonuclear Leukocytes.
Cardiovascular Disease Models. Sulfite Oxidase Deficiency in the Hepatic
Disease Model: A High-Risk Factor in Sulfur Dioxide, Sulfite, and Bisulfite
Toxicity, and Possible Animal Models. Respiratory Disorders.
8. DERMATOXICITY: PREDICTIVE MODELS. Ocular Toxicity. Contact Dermatitis.
Allergic Hypersensitivity. Phototoxicity.
9. GENOTOXICITY: PREDICTIVE MODELS. The Relationship of Mutagenicity to
Carcinogenicity. Quantitative Interspecies Comparisons of Genetic Damage.
An Attempt to Establish the Biological Basis of Interspecies Predictions of
Mutation Rates.
10. DNA REPAIR: INTERSPECIES DIFFERENCES. Introduction. DNA Repair and
Carcinogenesis. Interspecies Comparisons of DNA Repair Processes. Summary.
11. TERATOGENICITY: PREDICTIVE MODELS. The Use of Predictive Animal Models
in Teratogenicity Testing Before the Thalidomide Tragedy. The Predictive
Potential of Animal Models. New Approaches. Interspecies Differences in
Metabolism. Comparative Placental Morphology and Function in Animal Models.
Discussion and Conclusions.
12 SCALING: AN ATTEMPT TO FIND A COMMON DENOMINATOR. Introduction. The
Scaling Concept. Pharmacokinetics: Dependence on Body Weight. The Use of
Scaling in Carcinogen Evaluation. The use of Allometry in Extrapolation: A
Summary. Lifespan, a Common Denominator for Interspecies Comparisons in
Carcinogenicity Studies: Another Example of Scaling Effects.
13 DOWNWARD EXTRAPOLATION. Establishing Dose-Response Relationships. Safety
Factors. Attempts to Determine Safe Doses for Carcinogens. Latency as a
Function of Dose in Cancer Development. Quantitative Approaches to Downward
Extrapolation. The Biological Plausibility of the Models. Attempts to
Validate Downward Extrapolation Models. The Use of Quantitative Risk
Evaluation by U.S. Regulatory Agencies.
14 ANIMAL EXTRAPOLATION: A SUMMARY. INDEX.
Predictive Toxicology. The Early Use of Animal Models. How Much Testing Is
Needed? Are Perfect Testing Schemes Possible? Inadequacies of Present
Predictive Schemes. Animal Rights, Humane Considerations, and Human Needs.
Educating the Public: Perception Versus Reality. Regulatory Needs.
2. ABSORPTION: INTERSPECIES DIFFERENCES. The Gastrointestinal Tract. Dermal
Absorption. Respiratory Tract Absorption.
3. INTESTINAL MICROFLORA. Introduction. Interspecies Differences. Summary.
4. TISSUE DISTRIBUTION: INTERSPECIES DIFFERENCES. Protein Binding. Biliary
Excretion. The Blood-Brain Barrier: The Toxicological Implications of
Interspecies Differences in Maturation. Interspecies Differences in the
Tissue Distribution of Mercury.
5. COMPARATIVE METABOLISM: THE PRINCIPAL CAUSE OF DIFFERENTIAL
SUSCEPTIBILITY TO TOXIC AND CARCINOGENIC AGENTS. General Principles.
Organophosphate Insecticides: A Specific Application. Other Examples.
6. A REEVALUATION OF THE RAT AS A LABORATORY ANIMAL.
7. ANIMAL MODELS FOR SELECTED HIGH-RISK GROUPS. Introduction. Hereditary
Blood Disorders. White Blood Cells: Interspecies Differences in the
Detoxification of Hydrogen Peroxide by Polymorphonuclear Leukocytes.
Cardiovascular Disease Models. Sulfite Oxidase Deficiency in the Hepatic
Disease Model: A High-Risk Factor in Sulfur Dioxide, Sulfite, and Bisulfite
Toxicity, and Possible Animal Models. Respiratory Disorders.
8. DERMATOXICITY: PREDICTIVE MODELS. Ocular Toxicity. Contact Dermatitis.
Allergic Hypersensitivity. Phototoxicity.
9. GENOTOXICITY: PREDICTIVE MODELS. The Relationship of Mutagenicity to
Carcinogenicity. Quantitative Interspecies Comparisons of Genetic Damage.
An Attempt to Establish the Biological Basis of Interspecies Predictions of
Mutation Rates.
10. DNA REPAIR: INTERSPECIES DIFFERENCES. Introduction. DNA Repair and
Carcinogenesis. Interspecies Comparisons of DNA Repair Processes. Summary.
11. TERATOGENICITY: PREDICTIVE MODELS. The Use of Predictive Animal Models
in Teratogenicity Testing Before the Thalidomide Tragedy. The Predictive
Potential of Animal Models. New Approaches. Interspecies Differences in
Metabolism. Comparative Placental Morphology and Function in Animal Models.
Discussion and Conclusions.
12 SCALING: AN ATTEMPT TO FIND A COMMON DENOMINATOR. Introduction. The
Scaling Concept. Pharmacokinetics: Dependence on Body Weight. The Use of
Scaling in Carcinogen Evaluation. The use of Allometry in Extrapolation: A
Summary. Lifespan, a Common Denominator for Interspecies Comparisons in
Carcinogenicity Studies: Another Example of Scaling Effects.
13 DOWNWARD EXTRAPOLATION. Establishing Dose-Response Relationships. Safety
Factors. Attempts to Determine Safe Doses for Carcinogens. Latency as a
Function of Dose in Cancer Development. Quantitative Approaches to Downward
Extrapolation. The Biological Plausibility of the Models. Attempts to
Validate Downward Extrapolation Models. The Use of Quantitative Risk
Evaluation by U.S. Regulatory Agencies.
14 ANIMAL EXTRAPOLATION: A SUMMARY. INDEX.